moexipril has been researched along with Hypertension in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.56) | 18.7374 |
| 1990's | 23 (58.97) | 18.2507 |
| 2000's | 15 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreevskaia, EM; Burkov, SG; Ivleva, AIa | 1 |
| Bicket, DP | 1 |
| Fisman, EZ; Pines, A | 1 |
| Chrysant, GS; Chrysant, SG | 2 |
| Spinar, J; Vítovec, J | 1 |
| Demel'khanova, TS; Ebzeeva, EIu; Iurchenko, KV; Kirichenko, AA; Novichkova, IuN; Riazantsev, AA | 1 |
| Belousov, IuB; Demidova, MA; Glezer, MG; Tkhostova, EB | 1 |
| Belousov, IuB; Demidova, MA; Leonova, MV; Tarasov, AV | 2 |
| Ivleva, AIa | 1 |
| Bakhmet'eva, TA; Karpov, RS; Pavliukova, EN; Puzyrev, KV | 1 |
| Frolova, LI; Ostroumova, OD; Paukov, SV | 1 |
| Ageev, FT; Chernina, GV; Kulev, BD; Orlova, IaA; Patrusheva, IF; Plisiuk, AG; Seredenina, EM | 1 |
| Bao, G; Edling, O; Feelisch, M; Gohlke, P; Unger, T | 1 |
| Aarsland, T; Dickstein, K; Ferrari, P; Stimpel, M; Todd, M | 1 |
| Fox, A; Persson, B; Stimpel, M; Widgren, BR | 1 |
| Fox, AA; Kaihlanen, PM; Stimpel, M; Whelton, A; White, WB | 1 |
| Chrysant, SG; Fox, AA; Stimpel, M | 1 |
| Fox, AA; Stimpel, M; White, WB | 1 |
| Abernethy, DR; Fox, AA; Stimpel, M | 1 |
| Stimpel, M; White, WB | 1 |
| Persson, B; Stimpel, M | 1 |
| Chrysant, SG; Stimpel, M | 2 |
| Chen, Y; Jee, WS; Ma, Y; Stimpel, M; Yamamoto, N | 1 |
| Fox, A; Jansen, T; Koch, B; Loh, I; Stimpel, M | 1 |
| Koch, B; Stimpel, M | 1 |
| Andrushchishina, TB; Ol'binskaia, LI | 1 |
| Brogden, RN; Wiseman, LR | 1 |
| Koch, B; Oparil, S; Stimpel, M | 2 |
| Koch, B; Stimpel, M; Weber, MA | 1 |
| Amah, G; Blacher, J; Raison, J; Safar, ME; Schiemann, AL; Stimpel, M | 1 |
| Agabiti-Rosei, E; Ambrosioni, E; Pirelli, A; Stimpel, M; Zanchetti, A | 1 |
| Koch, B; Stimpel, M; White, WB | 1 |
| Asmar, R; Goujoun, B; Hlawaty, M; Jourde, M; Maldonado, J; Olszowska, M; Sayegh, F; Tracz, W; Vincent, M | 1 |
| Hayashi, CM; Lakatos, I; McClelland, DL; Rosenkranz, RP | 1 |
6 review(s) available for moexipril and Hypertension
| Article | Year |
|---|---|
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Hypertension; Randomized Controlled Trials as Topic; Renal Insufficiency; Tetrahydroisoquinolines | 2003 |
Pharmacological profile and clinical use of moexipril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Delayed-Action Preparations; Humans; Hypertension; Tetrahydroisoquinolines | 2003 |
Pharmacological and clinical profile of moexipril: a concise review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bone and Bones; Diuretics; Drug Combinations; Heart; Humans; Hydrochlorothiazide; Hypertension; Kidney; Liver; Multicenter Studies as Topic; Prodrugs; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 2004 |
[Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hypertension; Postmenopause; Tetrahydroisoquinolines; Treatment Outcome | 2006 |
Moexipril. A review of its use in the management of essential hypertension.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hypertension; Isoquinolines; Male; Prodrugs; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 1998 |
22 trial(s) available for moexipril and Hypertension
| Article | Year |
|---|---|
[Preventive pharmacotherapy in arterial hypertension: problems of clinical assessment of drugs in women].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Tetrahydroisoquinolines; Treatment Outcome | 2009 |
MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Practice Guidelines as Topic; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 2005 |
[Assessment of the effect of angiotensin converting enzyme inhibitor moexipril on the functional state of vascular wall in patients with I - III degree arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Vessels; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Tetrahydroisoquinolines; Treatment Outcome | 2007 |
Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines | 1994 |
Antihypertensive effects of moexipril, a new ACE inhibitor, as add-on therapy to nifedipine in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Nifedipine; Renin; Tetrahydroisoquinolines | 1995 |
Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Prodrugs; Tetrahydroisoquinolines | 1995 |
Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Renin; Tetrahydroisoquinolines; Verapamil | 1995 |
Long-term efficacy and safety of moexipril in the treatment of hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines | 1994 |
Moexipril in the treatment of mild to moderate essential hypertension: comparison with sustained-release verapamil.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Prodrugs; Tetrahydroisoquinolines; Verapamil | 1995 |
Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Prognosis; Tetrahydroisoquinolines | 1995 |
Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Prodrugs; Single-Blind Method; Tetrahydroisoquinolines | 1996 |
A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Delayed-Action Preparations; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Verapamil | 1996 |
Moexipril versus captopril in patients with mild to moderate hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dizziness; Double-Blind Method; Fatigue; Female; Headache; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Prodrugs; Tetrahydroisoquinolines | 1996 |
Antihypertensive treatment with moexipril plus HCTZ vs metoprolol plus HCTZ in patients with mild-to-moderate hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Metoprolol; Middle Aged; Tetrahydroisoquinolines | 1997 |
[The effect of the new angiotensin-converting enzyme inhibitor moexipril on the circadian rhythms of arterial pressure in hypertension patients].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Female; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Prodrugs; Tetrahydroisoquinolines; Time Factors | 1997 |
Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Placebos; Racial Groups; Sex Factors; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1998 |
Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Cholesterol; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Lipids; Middle Aged; Postmenopause; Prospective Studies; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Uric Acid | 1998 |
Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Female; Humans; Hypertension; Isoquinolines; Lipids; Middle Aged; Obesity; Postmenopause; Tetrahydroisoquinolines | 1998 |
Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Hormone Replacement Therapy; Humans; Hypertension; Isoquinolines; Middle Aged; Postmenopause; Renin; Tetrahydroisoquinolines; Time Factors; Vascular Resistance | 1998 |
Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Hormone Replacement Therapy; Humans; Hypertension; Isoquinolines; Middle Aged; Postmenopause; Tetrahydroisoquinolines | 1999 |
Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Isoquinolines; Middle Aged; Nitrendipine; Postmenopause; Prodrugs; Tetrahydroisoquinolines | 1999 |
Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Prodrugs; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1997 |
11 other study(ies) available for moexipril and Hypertension
| Article | Year |
|---|---|
[The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bone Density; Climacteric; Data Interpretation, Statistical; Female; Humans; Hypertension; Middle Aged; Tetrahydroisoquinolines; Time Factors; Treatment Outcome | 2005 |
[Moexipril influence on quality of life in postmenopausal women with arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Postmenopause; Quality of Life; Tetrahydroisoquinolines; Time Factors; Treatment Outcome | 2005 |
[Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Tetrahydroisoquinolines; Treatment Outcome | 2006 |
[Investigation of efficacy of cardiovascular drugs in women].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Drug Prescriptions; Female; Humans; Hypertension; Hypolipidemic Agents; Male; Menopause; Sex Distribution; Tetrahydroisoquinolines; Treatment Outcome | 2006 |
[Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation | 2006 |
[Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Severity of Illness Index; Tetrahydroisoquinolines; Treatment Outcome | 2006 |
Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Enalapril; Hypertension; Isoquinolines; Lung; Male; Rabbits; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines; Time Factors | 1995 |
Moexipril: another ACE inhibitor for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Clinical Trials as Topic; Humans; Hypertension; Intestinal Absorption; Isoquinolines; Tetrahydroisoquinolines | 1995 |
Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Estradiol; Female; Hypertension; Isoquinolines; Menopause; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Tibia | 1995 |
Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines; Ultrasonography | 2002 |
Diuretic effects of an ACE inhibitor, RS-10085, and hydrochlorothiazide in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Natriuresis; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines | 1989 |